March 29, 2019
SymBio Pharmaceuticals LimitedFuminori Yoshida
Representative Director
President and Chief Executive Officer(Securities Code: 4582)

Notice of Shareholder Voting Results for the14th Ordinary General Meeting of Shareholders
SymBio Pharmaceuticals Limited (“the Company”) hereby announces the shareholder voting results
for the 14th Ordinary General Meeting of Shareholders held on March 28th, 2019 (the “Shareholders’Meeting”) as below. Matters for resolution were approved as proposed by the exercise of voting rights
in advance (by postal mail or via the internet) together with the votes exercised at the Shareholders’Meeting.
1. Resolutions
Proposal 1: Ratio of the reverse stock split
The reverse stock split will be a one-for-four consolidation of the Company’s common stock.
Proposal 2: Changes to a portion of the Articles of Incorporation
To decrease the Company’s total number of authorized shares to 41,750,000 in accordance with thereverse stock split included in Proposal 1.
Proposal 3: Election of Six (6) Directors
To elect Fuminori Yoshida, Kazuo Asakawa, Kenji Murata, Shigetoshi Matsumoto, Bruce David
Cheson and Rockford Douglas Norby as Directors of the Company.
Proposal 4: Election of Three (3) Auditors
To elect Kiyoshi Watanabe, Kesao Endo and Eiji Ebinuma as Auditors of the Company.
Proposal 5: Election of One (1) Substitute Auditor
To elect Takashi Watanabe as Substitute Auditor of the Company.

12. Number of voting rights expressing approval, disapproval, voting abstention, or counted as invalid,
and requirements for the proposed resolutions to be approved and the voting outcome
Total number of voting rights:

823,922

Total number of voting rights exercised (including votes exercised at the Shareholders’ Meeting):
375,198
Matters for Resolution

Approval Disapproval Invalid
Require(number of (number of (number ofmentvotes)
votes)
votes)

VotingOutcome(%)

Proposal 1
327,654

42,2400(*1)

Approved(87.33)

335,182

34,7050(*1)

Approved(89.34)

Fuminori Yoshida

357,874

11,9640

Kazuo Asakawa

358,691

11,1470

Kenji Murata

358,060

11,7780(*2)

Approved(95.40)Approved(95.61)
Approved(95.45)
Approved(95.58)
Approved(95.17)
Approved(95.04)(*2)

Approved(96.16)
Approved(96.02)
Approved(96.22)(*2)

Approved(95.94)

Ratio of the reverse stock split
Proposal 2
Changes to a portion of the Articles ofIncorporation
Proposal 3

Election ofSix (6)Directors

Shigetoshi Matsumoto

358,567

11,2710

Bruce David Cheson

357,008

12,8300

Rockford Douglas Norby356,550

13,2880

Kiyoshi Watanabe

360,734

9,104

0

Kesao Endo

360,226

9,612

0Eiji Ebinuma

360,945

8,893

0

Takashi Watanabe

359,905

9,909

0Proposal 4

Election ofThree (3)
Auditors

Proposal 5
Election ofOne (1)SubstituteAuditor*1*2

Shareholders holding more than one-third of all shareholder voting rights voted at theShareholders’ Meeting, with more than two-third of voting to approve all resolutions.
Shareholders holding more than one-third of all shareholder voting rights voted at theShareholders’ Meeting, with more than fifty percent (50%) voting to approve all resolutions.

23. Reason for a portion of the votes exercised at the Shareholders’ Meeting not reflected in totals
As the proposed resolutions were approved certainty based on the total of confirmed advance votes
and votes exercised in person at the Shareholders’ Meeting, certain votes for or against, orabstentions, are not reflected in the above totals.
[Contact]
Investor Relations
Tel: +81(0)3 5472 11253